Connecting Type 1 and Type 2 Diabetes through Innate Immunity
Justin Iver Odegaard, Ajay Chawla · Cold Spring Harbor Perspectives in Medicine · 2012
The escalating epidemic of obesity has driven the prevalence of both type 1 and 2 diabetes mellitus to historically high levels. Chronic low-grade inflammation, which is present in both type 1 and type 2 diabetics, contributes to the pathogenesis of insulin resistance. The accumulation of activated innate immune cells in metabolic tissues results in release of inflammatory mediators, in particular, IL-1β and TNFα, which promote systemic insulin resistance and β-cell damage. In this article, we discuss the central role of innate immunity and, in particular, the macrophage in insulin sensitivity and resistance, β-cell damage, and autoimmune insulitis. We conclude with a discussion of the therapeutic implications of this integrated understanding of diabetic pathology.
Cited by 186 works. doi:10.1101/cshperspect.a007724 Open-access PDF
Authors
References
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- Obesity is associated with macrophage accumulation in adipose tissue
- Actual Causes of Death in the United States, 2000
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
- Inflammation and metabolic disorders
- Alternative activation of macrophages
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
- Cellular mechanisms of insulin resistance
- Insulin signalling and the regulation of glucose and lipid metabolism